Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;83(2):e4-e5.
doi: 10.1016/j.jinf.2021.06.024. Epub 2021 Jun 30.

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers

Gian Luca Salvagno  1 , Brandon M Henry  2 , Laura Pighi  1 , Simone De Nitto  1 , Gian Luca Gianfilippi  3 , Giuseppe Lippi  4
Affiliations
Comment

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers

Gian Luca Salvagno et al. J Infect. 2021 Aug.
No abstract available

Keywords: Antibodies; COVID-19; Immune response; SARS-CoV-2; Vaccination.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no relevant competing interest to disclose in relation to this work.

Figures

Fig. 1
Fig. 1.
Total anti-SARS-CoV-2 S antibodies response in healthcare workers undergoing Pfizer BNT162b2 mRNA vaccination. Serum samples were drown at baseline, 21 days after the first vaccine dose, 30 days after the second vaccine dose (50 days after the first vaccine dose) and 3 months after the first vaccine dose in both anti-SARS-CoV-2 seronegative and seropositive subjects. Results are shown as median and interquartile range. The green arrows indicate the two vaccine doses administration. * p<0.001 SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
See this image and copyright information in PMC

Comment on

References

    1. Tré-Hardy M., Cupaiolo R., Wilmet A., Beukinga I., Blairon L. Waning antibodies in SARS-CoV-2 naïve vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers. J Infect. 2021 doi: 10.1016/j.jinf.2021.06.017. Jun 20:S0163-4453(21)00314-5Epub ahead of print. - DOI - PMC - PubMed
    1. Salvagno G.L., Henry B.M., di Piazza G., Pighi L., De Nitto S., Bragantini D. Anti-SARS-CoV-2 receptor-binding domain total antibodies response in seropositive and seronegative healthcare workers undergoing COVID-19 mRNA BNT162b2 vaccination. Diagn (Basel) 2021;11(5):11832. - PMC - PubMed
    1. Eberhardt K.A., Dewald F., Heger E., Gieselmann L., Vanshylla K., Wirtz M. Evaluation of a new spike (S)-protein-based commercial immunoassay for the detection of anti-SARS-CoV-2 IgG. Microorganisms. 2021;9:733. - PMC - PubMed
    1. Lippi G., Henry B.M., Plebani M. Anti-SARS-CoV-2 antibodies testing in recipients of COVID-19 vaccination: why, when, and how? Diagn (Basel) 2021;11:941. - PMC - PubMed